Department of Rehabilitation and Movement Science, University of Vermont 5, Burlington, VT, USA.
Department of Orthopedics and Rehabilitation, University of Vermont, Burlington, VT, USA.
J Man Manip Ther. 2023 Aug;31(4):279-286. doi: 10.1080/10669817.2022.2137350. Epub 2022 Oct 27.
Characterize trajectory and predictors of patient acceptable symptom state (PASS) defined recovery at 6 months.
Individuals with musculoskeletal shoulder pain (n = 140) completed patient-reported disability and PASS at baseline, 1 and 6 months. The PASS was categorized into 3 trajectory groups; 1.) Early Recovery (answered yes to PASS at 1 and 6-months), 2.) Delayed Recovery (PASS-yes only at 6-months), and 3.) Unrecovered. Mixed models characterized the trajectory between PASS-groups using SPADI and QDASH disability change scores. Logistic regression identified predictors of Early Recovery versus Delayed+Unrecovered groups.
PASS-defined recovery rates by group were Early Recovery (58%), Delayed Recovery (22%), and Unrecovered (20%). A group main effect indicated lower disability over time in the Early Recovery versus Unrecovered (QDASH mean difference = 11(2.4); p = 0.001; SPADI mean difference = 12(3); p < 0.001). The odds of an Early Recovery slightly increased with greater change scores on the SPADI (odds ratio = 1.06, 95%CI:1.02,1.11; p = 0.004) and QDASH (odds ratio = 1.08, 95%CI:1.03,1.13; p = 0.003) over the first month of treatment.
Recovery trajectories of patients indicate differing responses to treatment despite overall improvements over the first month of treatment. Incorporating both patient-reported disability (SPADI, QDASH) and acceptable satisfaction (PASS) may aid in determining recovery trajectory, but more evidence is needed to be clinically useful.
描述患者可接受症状状态(PASS)定义的 6 个月恢复的轨迹和预测因素。
患有肌肉骨骼肩痛的个体(n=140)在基线、1 个月和 6 个月时完成了患者报告的残疾和 PASS。PASS 分为 3 个轨迹组;1. 早期恢复(在 1 个月和 6 个月时回答 PASS-是),2. 延迟恢复(仅在 6 个月时回答 PASS-是),和 3. 未恢复。使用 SPADI 和 QDASH 残疾变化评分,混合模型描述了 PASS 组之间的轨迹。逻辑回归确定了早期恢复与延迟+未恢复组的预测因素。
按组计算的 PASS 定义的恢复率分别为早期恢复(58%)、延迟恢复(22%)和未恢复(20%)。组间主要效应表明,早期恢复组的残疾程度随时间降低,与未恢复组相比(QDASH 平均差异=11(2.4);p=0.001;SPADI 平均差异=12(3);p<0.001)。在第一个月的治疗中,SPADI(比值比=1.06,95%CI:1.02,1.11;p=0.004)和 QDASH(比值比=1.08,95%CI:1.03,1.13;p=0.003)的变化评分越大,早期恢复的可能性略高。
尽管在第一个月的治疗中总体上有所改善,但患者的恢复轨迹表明对治疗有不同的反应。结合患者报告的残疾(SPADI、QDASH)和可接受的满意度(PASS)可能有助于确定恢复轨迹,但需要更多的证据才能具有临床意义。